Insights From Technical Analysis
Mithril Silver and Gold (ASX: MTH): Copalquin Resource Growth Meets a Key Chart Test
Mithril Silver and Gold (ASX: MTH) is advancing its Copalquin district in Mexico, where Target 1 now hosts over 600,000 ounces of gold equivalent. Drilling continues across newer targets, while shares remain in a downtrend, needing a strong break above resistance to signal a reversal.
Bubs Australia (ASX: BUB): BUB's Rally Could Be Just Getting Started
Bubs Australia enters FY27 with permanent FDA approval, wider US distribution and strong American revenue growth. The company is expanding retail channels and rebuilding other markets, but higher freight costs, tariffs, negative EBITDA, and working-capital demands keep profitability and execution in focus.
AML3D (ASX: AL3): Submarine Parts Order Lifts Shares Toward a Key Chart Level
AML3D (ASX: AL3) shares jumped after securing a first US Navy submarine parts order from Austal USA, building on record FY26 revenue. Trading above key support, the stock now tests a technical trigger level, with a confirmed breakout above $0.165 needed to signal further upside.
HeraMED (ASX: HMD)'s Lee Health Deal: A Small Contract with a Much Bigger US Ambition
HeraMED (ASX: HMD) launched a US$317,200 commercial deployment of its HeraCARE maternity platform at Lee Health, Florida, following a successful pilot. The deal, integrated with Epic EMR, is scalable and serves as a reference case for expanding US hospital partnerships, Philips channels, and rural healthcare programs.
EchoIQ (ASX: EIQ) Crisis Decoded: Regulatory Setback, Not Financial Collapse
EchoIQ shares plunged 60% after the FDA issued an NSE notice blocking its heart-failure AI product from the US market. Despite panic selling, strong cash reserves, an active second product, and a management options grant suggest this is a regulatory setback, not a financial collapse.
.webp&w=828&q=75)
Titomic (ASX: TTT): US Air Force Contract Win Follows $16.5 Million Capital Raise
Titomic (ASX: TTT) shares rallied after a US$5 million Air Force contract, following a $16.5 million placement. The advanced manufacturer, still loss-making, is progressing a US redomiciliation while shares test key support with a potential trendline breakout ahead.